Tumor mutational burden in lung cancer: a systematic literature review
Metrics: PDF 1116 views | Full Text 2151 views | ?
Connor Willis1, Michelle Fiander1, Dao Tran2, Beata Korytowsky3, John-Michael Thomas3, Florencio Calderon3, Teresa M. Zyczynski3, Diana Brixner1 and David D. Stenehjem1,2
1 Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA
2 Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, Duluth, MN, USA
3 Bristol-Myers Squibb Company, Lawrenceville, NJ, USA
Keywords: biomarkers; chemotherapy; immunotherapy; lung cancer; PD-L1
Received: June 14, 2019 Accepted: September 16, 2019 Published: November 12, 2019
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.